So far, very little attention has been given to a potential synergism between STAT5a and estrogen signaling, especially in the context of DCIS formation and progression, and which might also explain differing roles of STAT5a in breast cancer. This evidence concerns the gene STAT5A and ductal breast carcinoma in situ.